How Use of Radioiodine Is Changing According to Risk Groups in Well Differentiated Thyroid Cancer?
Journal Title: Nuclear Medicine Seminars - Year 2021, Vol 7, Issue 1
Abstract
Many aspects of patient management in thyroid cancers including I-131 use are based on retrospective data or expert opinions and still debatable. With the increasing use of ultrasonography, demographics of thyroid cancers started to change starting from 1990s. Most of the newly diagnosed thyroid cancers are consisting of small intrathyroidal low risk tumors. The standard and intensive treatments and screening programs which failed to show any survival benefits has started arguments of over-treatment in thyroid cancers. Individualized treatment strategies based on changing demographic of thyroid cancer resulted in recommendation of less surgery, loosened follow-up protocols and less I-131 use as well. However, the need of re-interpretation of I-131 use is not a result of decreased effectiveness of radioiodine but rather increased numbers of surgically cured patients which would not benefit from I-131 therapy. Although new approaches will not change the use of I-131 in metastatic diseases, ablative and adjuvant use of I-131 needs to be re-considered within this perspective. These review aims to discuss changing role of I-131 in light of guidelines but a wider perspective to bring proposals which could facilitate our daily practice.
Authors and Affiliations
Seyfettin Ilgan
Keywords
Related Articles
- EP ID EP693435
- DOI 10.4274/nts.galenos.2021.0001
- Views 102
- Downloads 0
Developments in Pain Imaging
In order to determine the etiology of chronic pain, radiological imaging tools like computed tomography (CT) and magnetic resonance imaging (MRI) are usually used. Except for the anatomical data that the radiological ima...
Practical Guidance on Peptide Receptor Radionuclide Therapy
Peptide receptor radionuclide therapy (PRRT) have been successfully used for the past 20 years to target metastatic or inoperable neuroendocrine tumors expressing the somatostatin receptors. Both prospective and retrospe...
Good Radiopharmacy Practice (GRP): Personnel and Training
Radiopharmaceuticals are medical products that are used for diagnosis and/or treatment in humans and containing one or more radionuclides (radioisotopes). The shelf life and expiry period of the radiopharmaceutical prepa...
F-18 FDG PET/CT Practice Guideline in Oncology
Positron emission tomography (PET) is a tomographic imaging method that shows three-dimensional distribution of radiopharmaceuticals which are labelled with positron emitter radionuclides. Today most widely used PET radi...
TSNM; Good Radiopharmacy Practice Design and Standards for the Hot Laboratory
Radiopharmacy laboratory (hot laboratory) is a laboratory where radiopharmaceuticals are prepared, stored and patient doses are dispensed in accordance with the radiation safety and aseptic working rules. Although differ...